Global Veterinary Artificial Insemination Market

Assisted reproductive technology is based on the surgical removal of eggs from women’s ovaries and then fusing them with men’s sperm in the laboratory to create embryos. These embryos are then inserted back into the woman’s body. ART uses donor eggs, donor sperm, or previously stored frozen embryos. Assisted reproductive technology (ART) is used for the treatment of infertility in either eggs or embryos. The main types of assisted reproductive technology are in-vitro fertilization (IVF), artificial insemination (AI-IUI), frozen embryo replacement (FER), and others. In-vitro fertilisation (IVF) is a complicated operation that involves collecting eggs and fertilising them with sperm in a lab to create embryos. These embryos are subsequently implanted into women's reproductive organs. The different procedure types include fresh non-donor, fresh donor, frozen donor, frozen non donor, embryo or egg banking and is used in hospitals, fertility clinics, others. The assisted reproductive technology (ART) market research report is one of a series of new reports from The Business Research Company that provides assisted reproductive technology (ART) market statistics, including assisted reproductive technology (ART) industry global market size, regional shares, competitors with a assisted reproductive technology (ART) market share, detailed assisted reproductive technology (ART) market segments, market trends and opportunities, and any further data you may need to thrive in the assisted reproductive technology (ART) industry. This assisted reproductive technology (ART) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global assisted reproductive technology market size grew from $31.4 billion in 2022 to $37.56 billion in 2023 at a compound annual growth rate (CAGR) of 19.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The assisted reproductive technology market size is expected to grow to $75.64 billion in 2027 at a CAGR of 19.1%. The rising number of infertility cases is expected to foster the assisted reproductive technology market in the coming years. Infertility is defined as the failure to become pregnant after a year of frequent and unprotected intercourse. Infertility affects both men and women, and is typically diagnosed by the inability to conceive. Infertility is treated using assisted reproductive technology (ART). Fertility therapies that work with both a woman's egg and a man's sperm are included in this. For instance, according to the UCLA Health, a US based health system, in 2020 around 15% of couples in the world have trouble in conceiving. Infertile couples are increasingly turning to assisted reproductive technology (ART), which is growing at a rate of 5% to 10% every year. Therefore, the rising number of infertility cases drives the growth of the assisted reproductive technology market. Technological advancements is a key trend gaining the popularity in the assisted reproductive technology market. Major companies operating in the assisted reproductive technology are focused on developing technological solutions to strengthen their position. For instance, in November 2020, NIPD Genetics, a Cyprus based biotechnology company launched Amfira PGT based on Target Capture Enrichment Technology. Amfira PGT is a preimplantation genetic test which can be employed during fertility treatment to improve the odds of becoming pregnant and giving birth to a healthy child. Amfira PGT can be used in In Vitro Fertilization (IVF) cycles to determine whether embryos are chromosomally normal (euploid) and have the best chance of culminating in a safe pregnancy and birth. In August 2021, Virtus Health Limited, an Australia-based company offering assisted reproductive technology acquired Adora Fertility and three-day hospitals from Healius Limited for $45.0 million. This acquisition will help Virtus health to strengthen its portfolio for in-vitro fertilization (IVF). Adora Fertility is an Australia-based company that provide assisted reproductive technology (ART) including IVF (In-vitro fertilisation) and ICSI (Intracytoplasmic Sperm Injection). Major players in the assisted reproductive technology market are Cooper Surgical Inc., Ferring B.V., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific, Boston Science Corporation, Anecova, Carolinas Fertility Institute, Microm Ltd. Europe was the largest region in the assisted reproductive technology market in 2022. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology (ART) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the assisted reproductive technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The assisted reproductive technology market includes revenues earned by entities by gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), and frozen embryo transfer (FET). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global assisted reproductive technology market is segmented - 1) By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing 2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking 3) By End-User: Hospitals, Fertility Clinics, Other End-Users

Veterinary vaccine refers to a biological preparation that stimulates the immune response of an animal against disease in order to reduce animal suffering and the transmission of microorganisms in the animal population and enhance the immunity power of animals by improving animal health, which also prevents the transmission of diseases from animals to humans. The various types of veterinary vaccines are live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccine types. Inactivated vaccines differ from live but attenuated vaccines as they are made up of dead, or inactivated, viruses and bacteria. The disease types are anaplasmosis, canine parvovirus, foot and mouth disease, Newcastle disease, distemper disease, influenza, and porcine reproductive and respiratory syndrome, and the application areas include livestock vaccines, and companion animal vaccines. The veterinary vaccines research report is one of a series of new reports from The Business Research Company that provides veterinary vaccines statistics, including veterinary vaccines industry global market size, regional shares, competitors with veterinary vaccines share, detailed veterinary vaccines segments, market trends and opportunities, and any further data you may need to thrive in the veterinary vaccines industry. The veterinary vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global veterinary vaccines market size will grow from $10.89 billion in 2022 to $11.57 billion in 2023 at a compound annual growth rate (CAGR) of 6.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary vaccines market size is expected to grow to $14.2 billion in 2027 at a CAGR of 5.3%. The increase in the number of animals suffering from a range of diseases is increasing the demand for vaccines to prevent and treat such diseases, thus driving the veterinary vaccines market According to the estimates from a report by the Animal and Plant Health Agency, a total of 3289 new TB herd incidents were detected in England Bovine tuberculosis is a chronic disease that usually affects animals such as cattle, but it can affect all mammals, causing a general state of illness, coughing and eventually leading to death. However, the disease can be treated with specific antibiotics that kill the TB bacteria. This rising prevalence of diseases in animals is expected to drive the veterinary vaccines market during the forecast period. High storage costs are acting as a major restraint on the growth of the veterinary vaccine market. Improper storage conditions and delays in shipping can cause vaccines to lose their desired immune properties. For example, during transportation, vaccines can undergo biodegradation, if they are not transported within the required temperature limits. Thus, special care is required for the transportation of the vaccines to maintain their efficiency, which increases the storage and transportation costs for the vaccines. According to a report published by the National Institute of Standards and Technology (NIST), approximately 35% of vaccines lost their potency during the shipment, as they were stored at abnormal temperatures. Thus, high storage costs for vaccines are expected to result in additional costs for manufacturing companies and limit the growth of the market. Companies in the veterinary vaccines market are increasingly looking for strategic partnerships and collaborations to enter into new geographies and to share research and development projects. For example, in 2020, the Pirbright Institute, a UK-based animal disease research institute, partnered with ECO Animal Health, a UK-based pharmaceutical company, and the Vaccine Group (TVG) to develop porcine respiratory and reproductive syndrome virus (PRRSV) vaccines. The vaccine group is a biotechnology company that develops animal vaccines and is based in Plymouth, UK. Similarly, MSD Animal Health, a division of Merck & Co with headquarters in the US, made a strategic partnership with Vinovo. This partnership will help MSD Animal Health to combine its unique broad vaccine product line and Vinovo’s vaccine delivery system to the vaccination process, thus improving bird welfare, and reducing vaccine reactions. Also, Wageningen bio veterinary research made a strategic alliance with Ceva with headquarters in Switzerland, to improve their Research on the global threat of emerging and reemerging diseases for animals. The veterinary vaccines market is regulated by authorities such as the European Medical Agency and the US Center for Veterinary Biologics. For instance, veterinary vaccine companies in Europe are required to adhere to European technical requirements mentioned in Annex 1, Title II, of Directive 2001/82/EC, as amended by Directive 2009/9/EC, and the European Pharmacopoeia (Ph. Eur.). According to these regulations, veterinary vaccines are required to undergo safety tests before getting approval, where vaccines are classified into activated vaccines and inactivated vaccines. For inactivated vaccines, each batch of vaccines should have a dose that is double the standard dose. In inactivated vaccines, each batch of vaccines should be ten times the standard dose for the active vaccines. Activated vaccines are usually tested by in vitro titration, while serological tests are commonly used for inactivated vaccines. Major players in the veterinary vaccines market are Boehringer Ingelheim GmbH, Merck Animal Health, Zoetis Inc., Eli Lilly and Company, Bayer AG (Bayer Animal Health), CevaSantéAnimale, Virbac, Biovac, Zoetis Animal Healthcare, and Hester Biosciences Ltd. North America was the largest region in the veterinary vaccines market in 2022. Asia-Pacific was the second-largest region in the global veterinary vaccines market. The regions covered in the global veterinary vaccines report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the veterinary vaccines market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The veterinary vaccines market consists of sales of messenger RNA vaccine, viral vector vaccine, and subunit vaccine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global veterinary vaccines market is segmented - 1) By Application: Livestock Vaccines, Companion Animal Vaccines 2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types 3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)

Companion animal vaccines are substances that are used to stimulate the production of antibodies and provide immunity against one or several diseases in pets such as dogs, birds, and cats. They are also used to improve food digestion, enhance immunity, enable animals to gain fat and weight, and generate good quality meat that is harvested for commercial purposes. The main products of companion animal veterinary vaccines are inactivated, live attenuated, recombinant, and other products. A recombinant vaccine is one that was created using recombinant DNA technology. This entails inserting DNA encoding an antigen (such as a bacterial surface protein) that triggers an immunological response into bacterial or mammalian cells, expressing the antigen in these cells, and then purifying it from them. The products are administered through oral, parenteral, and other routes of administration and are distributed through veterinary hospitals, veterinary clinics, pharmacies, drug stores, and other distribution channels. The companion animal veterinary vaccines research report is one of a series of new reports from The Business Research Company that provides companion animal veterinary vaccines statistics, including companion animal veterinary vaccines industry global market size, regional shares, competitors with companion animal veterinary vaccines share, detailed companion animal veterinary vaccines segments, market trends and opportunities, and any further data you may need to thrive in the companion animal veterinary vaccines industry. This companion animal veterinary vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global companion animal veterinary vaccines market size will grow from $3.25 billion in 2022 to $3.47 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global companion animal veterinary vaccines market size is expected to grow to $4.48 billion in 2027 at a CAGR of 6.6%. Increased pet ownership by Gen X and Gen Y adults contributed to the growth of the companion animal veterinary vaccine market during the historic period. According to the APPA, millennials, or Gen Y, represent the largest segment of pet owners for all types of pets. More than 80% of Gen Y and Gen Z own a dog, and 50% or less own a cat as a pet. Multiple pet ownership is also on the rise in some parts of the world. According to the 2019-2020 APPA National Pet Owners Survey, 67% of US households own pets, which is equal to 84.9 million homes. Pet owners are well aware of advanced facilities and are willing to spend a large amount of money on the health of their pets. Therefore, the rise in pet ownership aids in the growth of the companion animal veterinary vaccine market. The high cost of veterinary vaccines is expected to restrain the growth of the market. According to data from Harris Interactive, in the USA, households with pets spend about $1,000 on pet care. There are around 70% of households in the USA who own a pet and only 39% have enough in their savings to cover high spending related to pet care. According to a report by PET IQ, in the USA, nearly 28% of households experienced barriers to veterinary care in the past two years. 80% of pet owners are unable to obtain preventative care due to financial constraints. There are several instances when it happens that the pet owners cannot afford expensive animal treatment and this factor restrained the growth of the companion animal veterinary vaccines market. Usually, the average cost of the rabies vaccine varies, typically from about $1,200 to $6,500. Thus, the high cost of companion animal veterinary vaccines will restrain the growth of the market over the forecast period. Companies in the companion animal veterinary vaccine industry are increasingly collaborating and partnering with other players to drive product innovations. To succeed in the increasingly competitive veterinary market, companion animal veterinary vaccine companies are entering into new geographies and developing innovative products through sharing skills and expertise with other players. For instance, Merck & Co.’s subsidiary MSD Animal Health announced a strategic partnership with Vinovo B.V., a division of Viscon Hatchery Automation, the leading hatchery automation company, to provide a new standard in safe and effective Vinovo vaccination to improve bird welfare and reduce vaccine reactions. In February 2020, Zoetis, Inc., a US-based animal health company specializing in the discovery, development, production, and marketing of animal health drugs, acquired Ethos Diagnostic Science for an undisclosed amount. Through this acquisition, Zoetis continues to expand its diagnostics presence in order to provide American veterinarians with comprehensive services at an improved value. Ethos Diagnostic Science is a US-based veterinary diagnostic company pioneering in various types of diagnostic testing and clinical chemistry. Major players in the companion animal veterinary vaccines market are Boehringer Ingelheim, Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Virbac, Zoetis, ElancoCevaSante Animal S.A., Bayer Healthcare, NEOGEN CORPORATION, and ImmuCell Corporation. North America was the largest region in the companion animal veterinary vaccines market in 2022. Asia-Pacific was the second-largest region in the global companion animal veterinary vaccines market. The regions covered in the global companion animal veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the companion animal veterinary vaccines market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The companion animal veterinary vaccine market consists of sales of toxoid vaccines, viral vector vaccines, messenger RNA vaccines, and conjugated vaccines. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global companion animal veterinary vaccines market is segmented - 1) By Product: Inactivated, Live Attenuated, Recombinant, Other Products 2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration 3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels

Animal food is a type of feed prepared from ingredients, such as grains, oilseed mill products, and meat products for domestic animals. Pet food is a type of feed prepared from ingredients, such as grains, oilseed mill products, and meat products for consumption by dogs or cats. The main types of animal and pet food are pet food and animal food. Pet food is a specialty food used to feed domesticated animals and is formulated according to their nutritional needs. The various types of ingredients are animal derivatives, plant derivatives, and synthetic and are distributed through various channels such as supermarkets and hypermarkets, convenience stores, e-commerce, and other distribution channels. The animal and pet food research report is one of a series of new reports from The Business Research Company that provides animal and pet food statistics, including global and regional market size, competitors with animal and pet food shares, detailed animal and pet food segments, market trends and opportunities, and any further data you may need to thrive in the animal and pet food industry. This animal and pet food research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global animal and pet food market grew from $366.13 billion in 2022 to $398.07 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The animal and pet food market is expected to grow to $534.36 billion in 2027 at a CAGR of 7.6%. The animal and pet food market's growth is aided by the stable economic growth forecasted in many developed and developing countries. According to the International Monetary Fund (IMF), global GDP growth reached 3.3% in 2020 and 3.4% in 2021. Recovering commodity prices, after a significant decline in the historical period, are further expected to aid the market's growth. Developed economies are also expected to register stable growth during the forecast period. Additionally, emerging markets are expected to continue to grow slightly faster than developed markets in the forecast period. Stable economic growth is expected to increase investments in the end-user markets, thereby driving the market during the forecast period. The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the animal and pet food market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and has spread globally, including Western Europe, North America, and Asia. Food and beverage manufacturers depend on the supply of raw materials from domestic and international suppliers. As many governments restricted the movement of goods across countries and locally, manufacturers had to halt production due to a lack of raw materials. Also, restrictions on the trade of non-essential goods and fear of contamination through manufacturing facilities contributed to the decline. The outbreak had a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the animal and pet food markets will recover from the shock over the forecast period as it is a "black swan" event and not related to ongoing or fundamental weaknesses in the market or the global economy. Pet food manufacturing companies are using automation technologies such as advanced production lines and software solutions to improve safety and operational efficiency. These technologies automate formulation, extrusion, batching, drying, coating, and liquid delivery processes. This results in cost-effective processing and consistent product quality. For example, Champion Petfoods, a Canadian producer of pet food, has video-monitored production lines, with cooking processes connected through Rockwell hardware and software systems. It also uses bulk bins and conveying systems, votator heat exchangers, and advanced extrusion and drying systems. United Pet Group’s pet food manufacturing plant in St. Louis used FactoryTalk software from Rockwell Automation to reduce overtime by 10% and increase labor efficiency by 15%. Major companies in the animal and pet food market include Cargill Incorporated, Nestle S.A., New Hope Liuhe Co. Ltd., Charoen Pokphand Foods PCL, Bunge Limited, Diamond Pet Foods Inc., Mitsui, CJ Cheiljedang Corp, Land O'Lakes Inc., and J.M. Smucker Company. Asia-Pacific was the largest region in the animal and pet food market in 2022. Western Europe was the second-largest in the animal and pet food market. The regions covered in the animal and pet food market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the animal and pet food market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The animal and pet food market consists of sales of poultry feed, cattle feed, aquaculture feed, dry dog food, dog treats, wet dog food, wet cat food, dry cat food, cat treats, and other animal and pet food. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The animal and pet food market is segmented into pet food and animal food. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global animal and pet food market is segmented - 1) By Type: Pet Food, Animal Food 2) By Distribution Channel: Supermarkets/Hypermarkets, Convenience Stores, E-Commerce, Other Distribution Channels 3) By Ingredients: Animal Derivatives, Plant Derivatives, Synthetic Subsegments Covered: Dog And Cat Food, Other Pet Food, Poultry Feed, Cattle Feed, Aquaculture Feed, Other Animal Food

The probiotics in the animal feed refer to a live microbial feed additive that enhances the intestinal balance of the host animal. Probiotics are widely employed in animal feeding and are regarded as growth and health stimulators. Most probiotics used in animal nutrition are generated commercially and sold in liquid and solid forms. The main forms of probiotics in animal feed are dry and liquid. The dry probiotics are used in the animal feed in the form of dried powder form, tablets, and capsules. Dry probiotics come in a variety of shapes and sizes and are made using a freeze-drying method. The various sources of probiotics in animal feed include bacteria and yeast and fungi. They are used in feed of cattle, poultry, swine, aquaculture, and other applications. The probiotics in animal feed market research report are one of a series of new reports from The Business Research Company that provides Probiotics in animal feed market statistics, including probiotics in animal feed industry global market size, regional shares, competitors with probiotics in animal feed market share, detailed probiotics in animal feed market segments, market trends and opportunities, and any further data you may need to thrive in the probiotics in the animal feed industry. This probiotics in animal feed market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global probiotics in animal feed market size grew from $4.26 billion in 2022 to $4.62 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The probiotics in animal feed market size is expected to grow to $6.35 billion in 2027 at a CAGR of 8.2%. The growing demand for eggs and poultry meat contributes to the growth of probiotics in the animal feed market. The demand for eggs and poultry meat is increasing because of the rise in population, greater purchasing power, and urbanization. Moreover, increasing awareness about the nutrients and protein from eggs and meat are contributing towards their demand. Probiotics are used as an additive in the poultry feed, which keeps the poultry farm animals disease-free and boosts their immunity to produce more eggs and meat. For instance, in 2020, according to the Food and Agricultural Organisation of the United Nations, the global production of poultry meat increased from 9 to 133 million tonnes, and egg production increased from 15 to 93 million tonnes between 1961 and 2020. Poultry meat accounted for 40% of the total meat produced worldwide in 2020. Egg production increased by 150% in the last three decades. Thus, increased demand for eggs and poultry meat is expected to boost the demand for probiotics in the animal feed during the forecast period. Partnerships and collaborations is a key trend gaining popularity in the probiotics in the animal feed market. The companies operating in the probiotics in the animal feed market are focusing on establishing partnership with relevent technology companies to expand their product development activities and enhance their market reach. For instance, in September 2020, Proteon Pharmaceuticals, a Poland-based biotechnology company, partnered with DuPont Animal Nutrition. The partnership aims to use DuPont's reputable and trusted brand to help poultry producers in particular nations access Proteon's bacteriophage technology. In addition to improving Proteon's distribution capabilities and strengthening DuPont's product line, the partnership will help further reduce antimicrobial resistance (AMR) in farm animals. DuPont Animal Nutrition is a biotechnology research company that produces a wide range of feed enzymes, betaine, phytogenics, and probiotics. In January 2021, Novozymes, a Denmark-based biotechnology company specializing in research, development, and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients, acquired Microbiome Labs for $125 million. Through this acquisition, Novozymes will focus on probiotics for human use as a growth area. It offers the chance to advance our work in human health, expand its portfolio, and cement its leadership in the North American probiotics market. Microbiome Labs is an Illinois-based company that focuses on providing probiotic bacteriotherapy. Major players in the probiotics in animal feed market are Chr. Hansen, Koninklijke DSM N.V., DuPont, Evonik Industries, Land O'Lakes, Calpis Co., Ltd., Ohly, Lesaffre, Alltech, Novozymes, Unique Biotech, Archer Daniels Midland Company (ADM), Advance aqua bio technologies, Danisco A/S, and Kerry Group. Asia-Pacific was the largest region in the probiotics in animal feed market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the probiotics in animal feed market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the probiotics in animal feed market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The prebiotics in the amimal feed market consists of sales of lactobacillus, bacillus, streptococcus, pediococcus, enterococcus, bifidobacterium, and propionibacterium. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global probiotics in animal feed market is segmented - 1) By Form Type: Dry, Liquid 2) By Source Type: Bacteria, Yeast and Fungi 3) By Application Type: Cattle, Poultry, Swine, Aquaculture, Other Applications

Animal growth promoters and performance enhancers refer to the substances that are added to feeds as supplements or injections to increase feed utilization and growth in farm animals, as well as veterinary medicinal products that are administered to healthy animals in order to favourably influence the yield, quality, and/or growth of animal products. The main types of animal growth promoters and performance enhancers are antibiotic growth promoters and non-antibiotic growth promoters. Antibiotic growth promoters refer to the promoters that will enhance the health of the animal and increase productivity. These include natural chemicals such as microbial products, prebiotics, and probiotics; yeast products; enzymes and herbs; oils; and spices. The different types of animals that use animal growth promoters and performance enhancers include poultry, swine, livestock, aquaculture, and other animals. The animal growth promoters and performance enhancers research report is one of a series of new reports from The Business Research Company that provides animal growth promoters and performance enhancers statistics, including animal growth promoters and performance enhancers industry global market size, regional shares, competitors with animal growth promoters and performance enhancers share, detailed animal growth promoters and performance enhancers segments, market trends and opportunities, and any further data you may need to thrive in the animal growth promoters and performance enhancers industry. This animal growth promoters and performance enhancers research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global animal growth promoters and performance enhancers market size will grow from $13.73 billion in 2022 to $14.65 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global animal growth promoters and performance enhancers market size is expected to grow to $18.92 billion in 2027 at a CAGR of 6.6%. The growing demand for meat is a significant factor that will drive the market for animal growth promoters and performance enhancers. Animal growth promoters make the animal accumulate fat and weight, resulting in more meat production and a more expensive animal. Meat is a major protein source for many people around the world. According to a study by FAO, the production of meat has doubled in the last 30 years and increased four-fold since the mid-1960s. The production and consumption of meat are expected to continue to grow. By 2050, global meat consumption is projected to reach between 460 million and 570 million tons. This is expected to drive the animal growth promoters and performance enhancers market. Strict rules set by the US and European governments on the use of animal growth promoters and performance enhancers are restricting the animal growth promoter and performance enhancers market. For instance, Zoetis, the largest producer of animal medicines, is banned from selling antibiotics that promote faster growth in animals in the US and Europe. The US FDA has implemented a regulation that bans the use of antibiotics as feed supplements to help livestock and poultry grow faster. These regulations are expected to negatively impact the growth of the market. Companies in the market are increasingly investing in phytogenics for higher efficiency of growth promoters through natural means. Phytogenics, sometimes also referred to as botanicals or phytobiotics, are plant-based feed additives utilised in animal nutrition. They are derived from herbs, spices, and extracts. Phytochemicals can be used in solid, dried, and ground form or as extracts, and can also be classified as essential oils and oleoresins depending on the process used to derive the active ingredients. The use of phytogenics promotes increased feed intake, improved gut function, prevention of diarrhea, and antimicrobial and antioxidative effects in livestock. Companies such as Delacon, Cargill, and BIOMIN have invested in phytogenics. In June 2020, Elanco acquired Bayer Animal Health for $7.6 billion. This acquisition is expected to help Elanco expand its product profile and reach for medicines for pets and livestock. Bayer Animal Health is a division of Bayer HealthCare. Major players in the animal growth promoters and performance enhancers market are Merck Animal Health, Cargill, Royal DSM N.V., Vetoquinol S.A., Bupo Animal Health, Elanco Animal Health Inc., Alltech, Bayer Animal Health, Zoetis, and Bioniche Life Sciences. North America was the largest region in the animal growth promoters and performance enhancers market in 2022. Asia-Pacific was the second-largest region in the global animal growth promoters and performance enhancers market. The regions covered in the global animal growth promoters and performance enhancers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the animal growth promoters and performance enhancers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The animal growth promoters and performance enhancers market consists of sales of growth hormone medications, anabolic implants, bovine somatotropin, ß-agonists and probiotics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global animal growth promoters and performance enhancers market is segmented - 1) By Type: Antibiotic Growth Promoters, Non-Antibiotic Growth Promoters 2) By Animal Type: Poultry, Swine, Livestock, Aquaculture, Other Animals 3) By Nature of Chemicals: Microbial Products, Prebiotics And Probiotics, Yeast Products, Enzymes/Herbs, Oils And Spices

The farm animal healthcare refers to a proactive service that outlines steps for disease prevention, identification, and management in order to promote the health and wellbeing of farm animals. It ensures that disease, injury, and mortality among farmed animals are kept to a minimum. The main products of farm animal healthcare are vaccines, parasiticides, anti-infectives, medical feed additives, and other products. Vaccination is administering a vaccine into the body to create immunity to a specific disease. Vaccination improves animal health and welfare while increasing livestock productivity and preventing disease transmission from domestic and wild animals to people. The different applications include cattle, swine, poultry, fish, and sheep. The several end users include reference laboratories, point-of-care testing or in-house testing, veterinary hospitals and clinics, and others. The farm animal healthcare market research report is one of a series of new reports from The Business Research Company that provides farm animal healthcare market statistics, including farm animal healthcare industry global market size, regional shares, competitors with a farm animal healthcare market share, detailed farm animal healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the farm animal healthcare industry. This farm animal healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global farm animal healthcare market size grew from $18.7 billion in 2022 to $20.31 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The farm animal healthcare market size is expected to grow to $26.92 billion in 2027 at a CAGR of 7.3%. The increase in livestock is expected to drive the growth of the farm animal healthcare market going forward. Livestock refers to agricultural animals that are housed, reared, and used by people, such as cows, horses, and pigs. The need for farm animal healthcare services grows along with the increase of livestock since these services help protect animals from illnesses including swine flu and avian flu, which can also infect humans, workers, and veterinarians. For instance, according to a report published by the US Department of Agriculture in 2022, India's national herd of cattle increased from 1.2 million in 2021 to 306.7 million in 2022. Therefore, the growing livestock population will propel the farm animal healthcare market. Rapid developments in technology have emerged as a key trend gaining popularity in the farm animal healthcare market. Major companies in the farm animal healthcare sector are focused on developing new technologies to meet consumer demand and strengthen their position. For instance, in January 2020, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched the VAXXITEK HVT+IBD+ND vaccine based on trojan horse vaccine technology to protect poultry from three types of diseases. This vaccine technology is similar to a trojan horse in that it protects against disease by employing a non-pathogenic substance as a vector to carry pathogen-protective genes VAXXITEK HVT+IBD+ND builds a solid immune foundation and provides enhanced protection against marek's disease, infectious bursal disease (classic and variant kinds), and newcastle disease. In April 2020, Heska Corporation, a US-based advanced veterinary diagnostic and specialty products company, acquired Scil Animal Care Company for $110 million. Through this acquisition, Heska Corporation aimed to expand the company with veterinarians and point-of-care analyzers to serve companion animals. Scil Animal Care Company is a US-based company that specializes in animal health laboratories and imaging diagnostic products and services. Major players in the farm animal healthcare market are Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Elanco, Merck, Merial (Sanofi), Virbac, Zoetis Animal Healthcare, Vetoquinol, Norbrook, Alivira Animal Health Limited, Phibro Animal Health, Intas Pharmaceuticals Ltd., Hester Bioscience, and Eli Lilly and Company. North America was the largest region in the farm animal healthcare market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the farm animal healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the farm animal healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The farm animal healthcare market includes revenues earned by entities by offering farm animal healthcare services such as farm animal health management, vaccination to poultry farm animals, vaccination knowledge management, trainings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global farm animal healthcare market is segmented - 1) By Product: Vaccines, Parasiticides, Anti-Infectives, Medical Feed Additives, Other Products 2) By Application: Cattle, Swine, Poultry, Fish, Sheep 3) By End User: Reference Laboratories, Point-of-care Testing or In-House Testing, Veterinary Hospitals and Clinics, Other End Users

Cattle feeds are a mixture of silage, grain, hay, supplement, salt, by-product, salt, mineral, and vitamin that are fed to cattle and domestic animals such as livestock. This helps in animal well-being in various aspects such as it increases milk production, and reproductive efficiency of the livestock. The main cattle feed ingredients include cereals, cakes and mixes, food wastages, and feed additives. Cereals are a rich source of energy and starch in cattle diets, containing 8–12% of crude protein. The commonly used cereals in animal feed are maize, barley, oats, wheat, and rice. The different cattle types include beef cattle, dairy cattle, and calves. The cattle feed is sold through distribution channels, including online and offline. The cattle feeds research report is one of a series of new reports from The Business Research Company that provides cattle feeds statistics, including cattle feeds industry global market size, regional shares, competitors with cattle feeds share, detailed cattle feeds segments, market trends and opportunities, and any further data you may need to thrive in the cattle feeds industry. This cattle feeding research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global cattle feed market size is expected to grow from $74.70 billion in 2022 to $77.09 billion in 2023 at a compound annual growth rate (CAGR) of 3.2%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cattle feed market is expected to reach $87.45 billion in 2027 at a CAGR of 3.2%. An increase in government subsidies for cattle is significantly contributing to the growth of the cattle feed market. Governments all over the world have increased subsidies for cattle rustling because of the growing importance of cattle meat and products like milk, eggs. These government subsidies allow farmers to obtain better quality cattle feed for their animals and offer better nutrition and care. For instance, in 2022, the government of India launched the National Livestock Mission (NLM) to develop the animal husbandry sector. The scheme offers loans and subsidies, including up to 50% subsidy, a loan facility to livestock farmers, SHGs, FPOs, and companies. Therefore, an increase in government subsidies for cattle drives the cattle feeding market. Technological advancements are a key trend gaining popularity in the cattle feed market. Companies are focusing on devising methods and platforms for enhancing feed quality and performance. For instance, in 2021, a US-based Cnossen Dairy partnered with a US-based farming technology company, Grov Technologies, to build a controlled environment feed centre to grow fresh feed throughout the year for cattle and livestock, using fewer resources and energy than conventional methods. The new centre would leverage machine learning growing protocols to consistently produce high-density nutrient feed (HDN). The new facility would offer cows with a highly nutritious, consistent feed year-round and also reduce the impact of droughts and climate change while also delivering more sustainably produced products to consumers. In December 2021, Dutch animal feed cooperatives, ABZ Diervoeding and De Samenwerking, announced a merger to form ABZ De Samen. Through this merger, ABZ De Samen expects to extend its reach and footprint across different geographies using the combined scale and capabilities of both companies. Major players in the cattle feeds market are Archer Daniel Midland Company, BASF Se, Cargill, Inc., Kemin Industries, Land O' Lakes Inc., Nutreco, Land O'Lakes, Inc., Godrej Agrovet Limited, Farmer's Grain Company, Biomin Holding GmbH, United Farmers Cooperative, DE HEUS. ALL, Charoen Pokphand Group, New Hope Group and Kent Corporation. Asia-Pacific was the largest region in the cattle feeds market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cattle feeds market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cattle feeds market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The cattle feed market consists of sales of grass-fed, corn-fed, barley-fed, and other cattle feed. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global cattle feeds market is segmented - 1) By Ingredients: Cereals, Cakes and Mixes, Food Wastages, Feed Additives 2) By Cattle Type: Beef Cattle, Dairy Cattle, Calves 3) By Distribution Channel: Offline, Online